NIH-funded research NIH-funded research

Liver Cirrhosis Network coordinating cirrhosis studies and a rosuvastatin trial

Official title: Liver Cirrhosis Network: Scientific and Data Coordination Center

Funded at Northwestern University · NIH-11473501 · Data updated 2026-11-12

This project follows people with liver cirrhosis over time and tests whether the cholesterol medicine rosuvastatin helps people with cirrhosis.

More Cirrhosis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 28, 2021
Project endJuly 31, 2026
Funding year2026
Award (this year)$274,035
NIH project number3U24DK130164-05S1
Project IDNIH-11473501 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a diagnosis of liver cirrhosis who meet the study's health and medication eligibility rules would be the main candidates for participation.

Less likely to help

People without liver cirrhosis or those who are medically ineligible (for example due to severe liver failure, conflicting medications, or pregnancy) would not be expected to benefit from joining this trial.

What this research studies

You would be part of a large group of people with liver cirrhosis who are followed over time to understand how the disease progresses. A smaller randomized trial within the network gives some participants rosuvastatin and others a matching placebo so researchers can compare outcomes. Northwestern University runs the central data and science coordination, including study design, monitoring, and statistical analysis. The team also manages drug supply and matching placebo pills so the trial can be run safely and fairly.

Why it matters

Potential benefit: If successful, this work could show whether rosuvastatin is safe and can reduce complications or improve outcomes for people with cirrhosis.

How similar studies have gone: Observational studies have suggested benefits of statins in cirrhosis but randomized trials are limited, so this trial builds on promising but not yet conclusive prior evidence.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Smith, Abigail — Northwestern University
  • Study coordinator: Smith, Abigail

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.